2nd NovAliX Conference - Biophysics in Drug Discovery 2015

Committees

Conference Chairman

Dr Jean-Paul RENAUD (NovAliX & RiboStruct, Illkirch, France)

Scientific Committee

Dr Ursula EGNER (Bayer, Berlin, Germany)
Dr Michael HENNIG (F. Hoffmann-La Roche Ltd., Villigen, Switzerland)
Dr Geoff HOLDGATE (AstraZeneca, Macclesfield, United Kingdom)
Prof. Rod HUBBARD (University of York & Vernalis, Cambridge, United Kingdom)
Dr Vincent MIKOL (Sanofi, Vitry-sur-Seine, France)
Dr Herbert NAR (Boehringer Ingelheim, Biberach, Germany)
Dr Johannes OTTL (Novartis Institute of Biomedical Research, Basel, Switzerland)
Dr Jean-Paul RENAUD (NovAliX & RiboStruct, Illkirch, France)
Dr Edward ZARTLER (Quantum Tessera Consulting, Collegeville, PA, United States)

Organised by

Sponsors

Welcome Reception Sponsor

Media Partners

Copyright 2019 LD Organisation sprl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys